ATAnna Alekseyevna Tsypurdeyeva

Anna Alekseyevna Tsypurdeyeva

*This is an algorithmically generated author record based on publicly available information.

Anna Alekseyevna Tsypurdeyeva has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Lipofilling in the comprehensive treatment of vulvar lichen sclerosus: pathogenetic rationale and first clinical results

    by Anna A. Tsypurdeeva, Julia V. Kudlay, Karina А. Zakuraeva, Elena I. Rusina, Maria I. Yarmolinskaya

    Vulvar lichen sclerosus is a chronic immune-mediated disease associated with inflammation, atrophy, fibrosis, and genital scarring. Although topical glucocorticosteroids remain the first-line therapy and are effective in controlling inflammatory symptoms, some patients develop persistent anatomical and functional impairment, including synechiae, vaginal stenosis, dyspareunia, and reduced quality of life. This supports the need for additional treatment approaches. This review article presents a series of three clinical cases involving patients aged 48, 55, and 62 years with verified vulvar lichen sclerosus with clinically significant scarring and atrophic changes. Treatment included lipofilling of the external genitalia using microfragmented autologous lipoaspirate obtained by closed double microfiltration; in two patients, the procedure was combined with laser dissection of synechiae. Treatment outcomes were assessed by clinical examination, symptom dynamics, photographic documentation, and restoration of vulvar anatomy and functional status. The follow-up period ranged from 1.5 to 6 months. In the short-term follow-up period, all patients showed a reduction in symptoms, including pain, itching, burning, and discomfort, as well as improved vulvar tissue elasticity. In patients with baseline synechiae, combined treatment resulted in restoration of the anatomical patency of the vaginal introitus, with no recurrence of synechiae during follow-up visits. Patients with baseline sexual dysfunction reported resumption of sexual activity. No adverse events, infectious complications, or signs of disease worsening were observed during the follow-up period. The presented clinical observations suggest that lipofilling, including its combination with laser dissection of synechiae, may be considered a potentially promising component of comprehensive treatment for patients with scarring and atrophic manifestations of vulvar lichen sclerosus. These findings are preliminary and require confirmation in prospective controlled studies with larger patient cohorts, using validated symptom and quality-of-life assessment scales and long-term follow-up.

  • Fertility preservation in a patient with stage 1 multiple primary endometrial and ovarian cancer during hormonal therapy using a levonorgestrel-releasing intrauterine system

    by Anna E. Protasova, Natalia D. Tsypurdeeva, Anna A. Tsypurdeeva, Konstantin Yu. Bobrov, Цыпурдеева Наталия Дмитриевна

    Preserving the fertility of patients with multiple primary gynecological malignancies is a pressing issue in reproductive medicine. Organ-preserving treatment, combined with assisted reproductive technology, enables these patients to achieve their reproductive plans. From August 2022 to May 2025, assisted reproductive technology programs were conducted to preserve fertility in a cancer patient with synchronous malignant neoplasm of the endometrium stage TIA1 and ovary stage T1a without signs of stromal invasion in a borderline endometrial tumor. The patient underwent successful primary organ-preserving treatment in 2018 and repeat treatment in 2020 for recurrent endometrial cancer. Given the absence of disease progression over two years, the patient entered a program of assisted reproductive technology to preserve fertility. From August 2022 to May 2025, she underwent 14 transvaginal follicle punctures in a natural cycle, followed by vitrification of 13 stage MII oocytes using a levonorgestrel-releasing intrauterine system. In 3 cases, oocytes were retrieved from the right ovary, in 10 cases from the left ovary, and in 1 case, no oocyte was retrieved from the left ovary. The patient was observed and examined every 3 months, while using a levonorgestrel-releasing intrauterine system. No signs of recurrence of ovarian cancer or endometrial cancer were detected.

  • Modern use of radiological diagnostic methods in patients with deep infiltrating endometriosis

    by Elizaveta M. Tcybuk, Elizaveta V. Shelaeva, Anna A. Tsypurdeeva, Maria I. Yarmolinskaya

    Endometriosis is one of the most heterogeneous diseases in both its clinical manifestations and forms, and its course. Deep infiltrating endometriosis is a severe form of endometriosis, which currently occurs in every fifth patient with this disease. In clinical practice, timely diagnosis is extremely important, which contributes to the early start of treatment of these patients. However, delays in diagnosis can reach many years for a number of reasons. Those range from underestimation of symptoms by women, to difficulties in differential diagnosis with many other diseases that have a similar clinical picture. Among other reasons, there could be the experience and qualifications of specialists involved in the management of patients with suspected endometriosis. This article presents a modern review of radiation methods for diagnosing deep infiltrating endometriosis such as various modes of ultrasound, magnetic resonance imaging, and computed tomography. The article provides current Russian and foreign literature on their advantages and disadvantages, the accuracy of diagnosing various forms of deep infiltrating endometriosis, as well as the possibility of staging and assessing the severity and prevalence of the disease using various visualization methods according to the existing classification systems. The effectiveness of preoperative diagnostics of deep infiltrating endometriosis simplifies the interaction between related specialists that treat these patients. It also allows for competent planning of the proposed surgical volume, predicting possible complications at the preoperative examination stage, and providing for preventive measures.

  • Clinical Pharmacology Handbook for Obstetricians and Gynecologists. Edited by Irina E. Zazerskaya, Mikhail V. Pchelintsev, Andrei N. Kubynin

    by Irina Zazerskaya, Mikhail Pchelintsev, Андрей Николаевич Кубынин, Надежда Анатольевна Антипова, Elena Araviiskaya, Arutyun Arutyunyan, Алина Юрьевна Бабенко, Татьяна Валерьевна Батракова, Ekaterina Belyaeva, Ofeliya Bettikher, et al.

    This clinical pharmacology handbook is organized according to the nosological principle of the ICD-10 classification and contains information on the necessary diagnostic and pharmacotherapeutic measures for conditions encountered in obstetric and gynecological practice. The book describes the drugs that are approved in the Russian Federation. The systematic organization of this large body of material allows the physician to easily determine a diagnostic and treatment plan based on current guidelines, select a drug by its international nonproprietary or brand name, verify its dosage, route of administration, and therapy duration, and provide a prescription. The handbook is intended for obstetricians and gynecologists to use in their daily practice. It will also be helpful to continuing education students at the departments of obstetrics and gynecology and clinical pharmacology.

  • Open Access

    The Effectiveness of Infertility Treatment Methods in Patients with Stage I–II Endometriosis

    by Almazov National Medical Research Centre, A.A. Efimova, Russian Federation Saint Petersburg, I.V. Gorelova, A.A. Tsypurdeeva, M.V. Rulev, I.E. Zazerskaya

    Aim. To evaluate the effectiveness of surgical treatment and assisted reproductive technologies (ART) for infertility associated with stage I–II endometriosis, according to the revised American Society for Reproductive Medicine (rASRM) classification. Design. Randomized study. Materials and methods. This study included 62 women aged 25 to 41 years with infertility and stage I–II endometriosis, determined by clinical symptoms and magnetic resonance imaging data. Patients were randomized into 2 groups: group 1 (laparoscopy) — surgical treatment of endometriosis, followed by planning a spontaneous conception within 12 months (n = 35); group 2 (ART) — treatment of infertility associated with endometriosis using ART methods (n = 27). Reproductive outcomes in group 1 were assessed after 1 year from the date of surgical treatment; in group 2 — based on the results of 3 attempts of embryo transfer as part of the use of ART methods. Results. Rate of pregnancy (group 1 — 34.3%; group 2 — 33.3%; p = 0.937), pregnancy termination (group 1 — 25%; group 2 — 44.4%; p = 0.397), childbirth (group 1 — 20%; group 2 — 14.8%; p = 0.643) did not differ significantly between treatment groups. Conclusion. Surgical treatment and the use of ART methods in the treatment of infertility in patients with stage I–II endometriosis are equally effective. The choice of method may depend on the patient’s preference, medical history, characteristics and disease stage, the presence of concomitant pathology, as well as the other factors of infertility. Keywords: endometriosis, magnetic resonance imaging, surgical treatment of endometriosis, laparoscopy, infertility, assisted reproductive technologies, in vitro fertilisation, hormonal treatment.

  • Impact of surgical treatment of endometriomas on ovarian reserve and reproductive outcomes

    by Arsenii S. Molotkov, Maria I. Yarmolinskaya, Anna A. Tsypurdeeva, Ярмолинская Мария Игоревна

    BACKGROUND: Endometriomas are most common during the reproductive years and have an extremely negative impact on ovarian reserve and fertility. In this case, the main method of treatment remains surgery, which inevitably injures healthy ovarian tissue. Assessing the impact of surgical treatment of endometriomas on ovarian reserve and fertility will help to optimize the management of patients of reproductive age with endometrioid cysts. AIM: The aim of this study was to evaluate the effect of surgical treatment on ovarian reserve and reproductive outcomes in patients with endometrioid cysts. MATERIALS AND METHODS: We analyzed the course of the disease in 289 patients with endometriomas. All patients underwent processing of medical histories and surgical protocols; then, 134 patients were surveyed in the long-term postoperative period (12–24 months after surgery) to gather data on complaints and age of the patients, the size of endometriomas, previous treatment, anti-Müllerian hormone level, and features of reproductive function implementation. RESULTS: Among patients who had pain before surgery, 52.8% of patients noted a complete absence of pain after surgery; in 26.4% of patients, pain significantly decreased. In 65.8% of patients who had dysmenorrhea before surgery, menstruation became painless. Among patients who complained of dyspareunia before surgical treatment, in 80% of patients, pain during sexual intercourse decreased or disappeared after surgery. After surgical treatment, 119 of 134 surveyed patients (88.8%) received drugs for hormonal therapy for endometriosis. After treatment, pregnancy occurred in 54 out of 82 patients interested in reproductive function. The average anti-Müllerian hormone level before treatment was 3.8 ± 1.8 ng/ml in the age group of 20–34 years and 1.9 ± 1.5 ng/ml in the age group of 35–45 years old; after treatment, 2.7 ± 2.0 ng/ml and 1.0 ± 1.8 ng/ml, respectively. CONCLUSIONS: Determining anti-Müllerian hormone level is one of the main methods for obtaining an idea of the patient’s ovarian reserve. At a young age and with not implemented reproductive function, it is mandatory to determine the ovarian reserve and consult a reproductive specialist before starting treatment. According to our results, surgical treatment of endometriomas is the most promising for overcoming infertility in young patients with endometriosis.

  • Giant uterine fibroids with chromosome 22 monosomy. A clinical case

    by Maria I. Yarmolinskaya, Anna A. Tsypurdeeva, Nikolai I. Polenov, Olga V. Malysheva, Alla S. Koltsova, Anna A. Pendina, Olga A. Efimova, Natalia S. Osinovskaya, Natalia Yu. Shved, Ярмолинская Мария Игоревна, et al.

    We present a clinical case of giant uterine fibroids in this research, with the peculiarity of surgical treatment and the course of the postoperative period described. A series of genetic studies specific to uterine fibroids was performed, namely, mutations in the MED12 gene, overexpression of the HMGA2 gene, and chromosomal imbalance. We did not detect mutations of exon 2 of the MED12 gene and an increase in the expression of the HMGA2 gene in the patients myomatous node sample. The molecular karyotype arr(22)1 (chromosome 22 monosomy) was established by comparative genomic hybridization in the tissue of giant uterine fibroids.

  • Open Access

    Modern approaches to performing organ-preserving operations in adenomyosis

    by Arsenii S. Molotkov, Maria I. Yarmolinskaya, Anna A. Tsypurdeeva, Maria A. Shalina, Ярмолинская Мария Игоревна

    The incidence of adenomyosis in young patients who have not realized their reproductive function is steadily increasing, with the tactics of surgical and drug treatment being an unresolved problem. In clinical practice, special attention is focused on the possibility of surgical treatment of adenomyosis with preservation of the uterus; and a variety of new options for such operations are proposed, as well as ways to optimize the treatment of such patients. This article summarizes our own and world experience in managing such patients. We present current views regarding the selection of patients for such interventions and determining the indications for surgery, and we herein highlight the technical features of such interventions. A particular attention is paid to management tactics being aimed at ensuring reproductive function implementation.


  • Borderline ovarian tumors: modern diagnostic criteria at the preoperative stage

    by Anna A. Tsypurdeyeva, Anna E. Protasova, Irina A. Solntseva, Lina I. Mikhelashvili

    AIM: The aim of this study was to define and standardize the clinical and diagnostic criteria for borderline ovarian tumors at the preoperative stage. MATERIALS AND METHODS: A retrospective analysis of 35 clinical case histories of patients with morphologically established borderline ovarian tumors has been conducted. Clinical and morphological data were analyzed: age, anamnesis, examination data, disease stage, histological study results. Laboratory parameters were assessed: CA-125 tumor marker level and ultrasound characteristics using criteria defined by IOTA, ADNEX and O-RADS groups. RESULTS: A single cyst with a solid component was a typical ultrasound type of borderline ovarian tumors (45.71%). The application of the simple IOTA rules in regards to evaluating the formations proved possible in 100% of the cases and the formation was regarded as undefined in 62.86% of the cases. In 51.43% of the cases, the formation belonged to O-RADS 4 (10% to 50% risk of malignancy). The study of CA-125 tumor marker levels showed insufficient sensitivity, only 57.14% of patients having the parameter above the norm. CONCLUSIONS: The application of the IOTA and O-RADS criteria allows for differentiating not only benign and malignant, but also borderline ovarian tumors, thus determining the choice of an organ-preserving treatment for patients of reproductive age.

  • Management of a patient diagnosed with ovarian cancer during pregnancy

    by Anna E. Protasova, Irina E. Zazerskaya, Anna A. Tsypurdeyeva, Ekaterina S. Shelepova, Elena D. Vyshedkevich, Inna A. Rizhinashvili, Alyona А. Sokolova

    Insufficient diagnosis of ovarian tumors during pregnancy and decreased oncological alertness constitute huge problems that can subsequently have an unfavorable outcome for both the pregnant woman and the fetus. The difficulties of diagnosing and treating ovarian cancer during pregnancy were demonstrated on the following clinical case example. In pregnant patient A. at 19-20 weeks of pregnancy, a lesion was found in the area of the right appendages (100.9 55.4 93.4 mm, V = 273 cm3), with many tissue partitions and parietal tissue inclusions. The growth of the neoplasm was noted (CA-125 884 U / ml) and the pain syndrome occurred in the patient at 23-24 weeks of pregnancy. Magnetic resonance imaging revealed a solid-cystic neoplasm of the right ovary (cystadenoma?) and surgery was performed in November 2019. Based on the results of histological examination, a high-grade serous ovarian cancer was diagnosed without signs of microsatellite instability MSI-H/dMMR (in the right ovary, in the biopsy of the left fallopian tube). The patient. received two cycles of polychemotherapy (TC scheme). The treatment was tolerated satisfactorily (CA-125 287.3 U / ml). At a gestational age of 34 6/7 weeks (January 2020), a simultaneous operation was performed, including a lower midline laparotomy, a lower uterine segment caesarean section, extirpation of the uterus with appendages, and an omentectomy. A boy was born (weight 2280 g, height 44 cm) with the Apgar score of 7/7 points, with no complications noticed in the postpartum period. Postoperative histological examination showed metastasis of carcinoma in the left ovary with signs of therapeutic pathomorphosis. The treatment was completed in March 2020 after six cycles of polychemotherapy.